drugset / Trial / NCT01085695

Study of E3810 for Healthy Japanese Male (Under Fasting Condition)

NCT01085695

Phase 1 Completed 16 enrolled Eisai Inc.
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the pharmacokinetics of rabeprazole under fasting condition.

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rabeprazole Small molecule 10 mg

Indications

No indication recorded.